10.22.20
Essity’s net sales in the third quarter of 2020 declined 11.9% compared with the corresponding period a year ago to SEK 28,677 million ($3.3 billion). Organic net sales, which exclude exchange rate effects, acquisitions and divestments, declined 5.1%, of which volume accounted for -5.1% and price/mix for 0.0%. Sales were negatively affected by the Covid-19 pandemic and related lockdowns. Organic net sales declined 7.7% in mature markets and 0.8% in emerging markets. Emerging markets accounted for 36% of net sales. Exchange rate effects reduced net sales by 7%. Acquisitions increased net sales by 0.2% and were largely attributable to the acquisition of ABIGO Medical AB.
Net sales declined 9% to SEK 11,115 million ($1.3 billion). Organic net sales declined 1.5%, of which volume accounted for -3.2% and price/mix for 1.7%. Organic net sales in mature markets declined 2.3%. In emerging markets, which accounted for 34% of net sales, organic net sales declined 0.3%. Exchange rate effects reduced net sales by 8%. Acquisitions increased net sales by 0.5%.
Sales were negatively affected by the Covid-19 pandemic as demand was temporarily impacted by the lockdowns as consumption decreased slightly when consumers spent more time in the home. For Incontinence Products, with Essity’s globally leading Tena brand, organic net sales declined 0.3%. The decline was related to Western Europe and North America, while net sales increased in emerging markets. In Medical Solutions, organic net sales decreased 4.5%, which was a substantial improvement compared with the second quarter of 2020. For Baby Care, organic net sales declined 2.8% related to Western Europe and emerging markets. For Feminine Care, organic net sales increased 0.1%, related to emerging markets.
Net sales declined 9% to SEK 11,115 million ($1.3 billion). Organic net sales declined 1.5%, of which volume accounted for -3.2% and price/mix for 1.7%. Organic net sales in mature markets declined 2.3%. In emerging markets, which accounted for 34% of net sales, organic net sales declined 0.3%. Exchange rate effects reduced net sales by 8%. Acquisitions increased net sales by 0.5%.
Sales were negatively affected by the Covid-19 pandemic as demand was temporarily impacted by the lockdowns as consumption decreased slightly when consumers spent more time in the home. For Incontinence Products, with Essity’s globally leading Tena brand, organic net sales declined 0.3%. The decline was related to Western Europe and North America, while net sales increased in emerging markets. In Medical Solutions, organic net sales decreased 4.5%, which was a substantial improvement compared with the second quarter of 2020. For Baby Care, organic net sales declined 2.8% related to Western Europe and emerging markets. For Feminine Care, organic net sales increased 0.1%, related to emerging markets.
